Comparison of Aminolevulinic Acid and Hexylester Aminolevulinate Induced Protoporphyrin IX Distribution in Human Bladder Cancer
- 1 August 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 170 (2) , 428-432
- https://doi.org/10.1097/01.ju.0000075054.38441.2d
Abstract
Successful photodynamic therapy of epithelial cancer requires a specific photosensitization of malignant tissue. We evaluate the intensity and localization of protoporphyrin IX (PpIX) in superficial transitional cell carcinoma and nonmalignant cells of the human bladder following topical administration of its precursor, either aminolevulinic acid (ALA) or hexylester aminolevulinate (HAL).Solutions of ALA or HAL were instilled into the bladder of 18 patients presenting with recurrent transitional cell carcinoma. The distribution of PpIX through the bladder wall was studied on frozen biopsies using fluorescence microscopy and correlated with pathological findings.Topical bladder instillation with 180 mmol (3%) ALA administered for 6 hours or 8 mmol (0.2%) HAL administered for 4 hours gave similar results regarding intensity and tissue distribution of PpIX fluorescence, whereas 8 mmol HAL administered for 2 hours followed by 2 hours of resting time (2+2 hours concept) induced a PpIX fluorescence twice as high. The fluorescence remained limited to cancer cells. Only a trace of PpIX fluorescence was observed in suburothelial connective tissue, that is chorion, but none in the bladder smooth muscle regardless of experiment conditions.HAL is an excellent precursor for PpIX synthesis in bladder cancer. With the 2+2 hour topical administration condition it yielded the highest PpIX fluorescence intensity and fluorescence contrast between normal and malignant urothelial cells. This approach allows us to optimize PpIX tissue distribution for photodynamic therapy in superficial bladder cancer.Keywords
This publication has 15 references indexed in Scilit:
- The Fluorescence Biodistribution And Kinetics Of Aminolevulinic Acid Induced Protoporphyrin IX In The Bladder Of A Rat Model With Orthotopic Urothelial CarcinomaJournal of Urology, 2002
- Photodynamic therapy in superficial bladder cancer: past, present and futureUrological Research, 2001
- OPTIMISATION OF THE FORMATION AND DISTRIBUTION OF PROTOPORPHYRIN IX IN THE UROTHELIUM: AN IN VITRO APPROACHJournal of Urology, 1999
- Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot studyBritish Journal of Cancer, 1999
- Biodistribution of Photofrin II® and 5-Aminolevulinic Acid-Induced Protoporphyrin IX in Normal Rat Bladder and Bladder Tumor Models: Implications for Photodynamic TherapyPhotochemistry and Photobiology, 1998
- Biodistribution of Protoporphyrin IX in Rat Urinary Bladder after Intravesical Instillation of 5-Aminolevulinic AcidJournal of Urology, 1996
- Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin FluorescenceJournal of Urology, 1996
- Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladderUrology, 1995
- New trends in photobiologyJournal of Photochemistry and Photobiology B: Biology, 1992
- Complications of Whole Bladder Dihematoporphyrin Ether Photodynamic TherapyJournal of Urology, 1989